IASLC Scientific Projects

As the data collection window for the 9th Edition is now closed, the IASLC encourages early applications to the 10th Edition of TNM Classification for Thoracic Cancers. Check back often as more information becomes available. 

To enhance our understanding of the current landscape surrounding biomarker testing in patients diagnosed with lung cancer globally, we urge IASLC members, healthcare practitioners, and other stakeholders to participate in this survey.

Overall Goal: To establish pathologic response in surgical resection specimens following neoadjuvant therapies as predictors of long-term clinical benefit in patients with stages II to III lung cancers.

This Atlas provides a comprehensive overview of all current and emerging molecular targets, specimen acquisition, available assays, and reporting and interpretation of molecular testing results from both a diagnostic and clinical perspective. 

The IASLC 's strategic initiative to advance the application of quantitative imaging for detection and management of early lung cancer especially through CT-based early lung cancer detection.

For years, the IASLC has been instrumental in convening multidisciplinary panels of experts who utilize real-world clinical lung cancer samples to establish evidence-based standards across the industry. Explore a selection of the IASLC's previous scientific projects.